Old Web
English
Sign In
Acemap
>
authorDetail
>
R. De Cataldo
R. De Cataldo
Neutropenia
Cytarabine
Oncology
Daunorubicin
Chemotherapy
2
Papers
322
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy: the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report of the Leukemia Cooperative Group of the European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group randomized phase III study AML-9
1998
Journal of Clinical Oncology
Löwenberg B
S. Suciu
Eric Archimbaud
Hans L. Haak
Pierre Stryckmans
R. De Cataldo
A. W. Dekker
Zwi N. Berneman
Antoine Thyss
J van der Lelie
Pieter Sonneveld
Giuseppe Visani
Georges Fillet
Hayat M
A. Hagemeijer
G. Solbu
R. Zittoun
Show All
Source
Cite
Save
Citations (51)
Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.
1998
Journal of Clinical Oncology
Löwenberg B
S. Suciu
Eric Archimbaud
Hans L. Haak
Pierre Stryckmans
R. De Cataldo
A. W. Dekker
Zwi N. Berneman
Antoine Thyss
J van der Lelie
Pieter Sonneveld
Giuseppe Visani
Georges Fillet
Hayat M
A. Hagemeijer
G. Solbu
R. Zittoun
Show All
Source
Cite
Save
Citations (271)
1